Cargando…

Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms

Systemic sclerosis (SSc) is a rare systemic autoimmune disease characterized by skin and organ fibrosis. The pathogenesis of SSc and its progression are poorly understood. The SSc intrinsic gene expression subsets (inflammatory, fibroproliferative, normal-like, and limited) are observed in multiple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahoney, J. Matthew, Taroni, Jaclyn, Martyanov, Viktor, Wood, Tammara A., Greene, Casey S., Pioli, Patricia A., Hinchcliff, Monique E., Whitfield, Michael L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288710/ https://www.ncbi.nlm.nih.gov/pubmed/25569146 http://dx.doi.org/10.1371/journal.pcbi.1004005

Ejemplares similares

A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis
por: Taroni, Jaclyn N., et al.
Publicado: (2017)

Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
por: Taroni, Jaclyn N., et al.
Publicado: (2015)

Molecular Signatures in Skin Associated with Clinical Improvement During Mycophenolate Treatment in Systemic Sclerosis
por: Hinchcliff, Monique, et al.
Publicado: (2013)

Correction: Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms
Publicado: (2015)

Regulator combinations identify systemic sclerosis patients with more severe disease
por: Wang, Yue, et al.
Publicado: (2020)

Experimentally-Derived Fibroblast Gene Signatures Identify Molecular Pathways Associated with Distinct Subsets of Systemic Sclerosis Patients in Three Independent Cohorts
por: Johnson, Michael E., et al.
Publicado: (2015)

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
por: Gordon, Jessica K., et al.
Publicado: (2015)

Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
por: Chakravarty, Eliza F., et al.
Publicado: (2015)

Egr-1 Induces a Profibrotic Injury/Repair Gene Program Associated with Systemic Sclerosis
por: Bhattacharyya, Swati, et al.
Publicado: (2011)

Identification of cell cycle–regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors
por: Grant, Gavin D., et al.
Publicado: (2013)

Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin
por: Johnson, Michael E., et al.
Publicado: (2019)

Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature
por: Derrett-Smith, Emma C., et al.
Publicado: (2017)

Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling
por: Di Benedetto, Paola, et al.
Publicado: (2019)

Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis
por: Spiera, Robert, et al.
Publicado: (2020)

Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis
por: Choreño-Parra, José Alberto, et al.
Publicado: (2022)

Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
por: Hinchcliff, Monique, et al.
Publicado: (2020)

High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis
por: Arron, Sarah T., et al.
Publicado: (2014)

Elevated Fibronectin Levels in Profibrotic CD14(+) Monocytes and CD14(+) Macrophages in Systemic Sclerosis
por: Rudnik, Michał, et al.
Publicado: (2021)

New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy
por: Romano, Eloisa, et al.
Publicado: (2021)

Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?
por: Lakota, Katja, et al.
Publicado: (2012)

Fibrosis in systemic sclerosis: common and unique pathobiology
por: Bhattacharyya, Swati, et al.
Publicado: (2012)

Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications
por: Manetti, Mirko, et al.
Publicado: (2019)

Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon
por: Teaw, Shannon, et al.
Publicado: (2023)

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis
por: François, Antoine, et al.
Publicado: (2013)

TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis
por: Laurent, Paôline, et al.
Publicado: (2021)

Profibrotic Effects of Endothelin-1 on Fibroblasts Are Mediated by Aldosterone In Vitro: Relevance to the Pathogenesis and Therapy of Systemic Sclerosis and Pulmonary Arterial Hypertension
por: Argentino, Giuseppe, et al.
Publicado: (2022)

Machine-learning classification identifies patients with early systemic sclerosis as abatacept responders via CD28 pathway modulation
por: Mehta, Bhaven K., et al.
Publicado: (2022)

High-throughput quantitative histology in systemic sclerosis skin disease using computer vision
por: Correia, Chase, et al.
Publicado: (2020)

Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors
por: Ciechomska, Marzena, et al.
Publicado: (2013)

Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic Sclerosis
por: Lakota, Katja, et al.
Publicado: (2015)

Assessment of diffuse myocardial fibrosis in systemic sclerosis by cardiac magnetic resonance imaging
por: Lee, Daniel C, et al.
Publicado: (2013)

Limited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injury
por: Pendergrass, Sarah A., et al.
Publicado: (2010)

Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis
por: Johnson, Michael E., et al.
Publicado: (2016)

The uPA System Differentially Alters Fibroblast Fate and Profibrotic Ability in Skin Fibrosis
por: Zou, Ming-Li, et al.
Publicado: (2022)

CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer
por: Ball, Michael S., et al.
Publicado: (2020)

Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts
por: Cipriani, Paola, et al.
Publicado: (2015)

Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies
por: Pendergrass, Sarah A., et al.
Publicado: (2012)

Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis
por: Milani, Martina, et al.
Publicado: (2021)

Cell-Type-Specific Profibrotic Scores across Multi-Organ Systems Predict Cancer Prognosis
por: Fan, Huihui, et al.
Publicado: (2021)

Cross-platform normalization enables machine learning model training on microarray and RNA-seq data simultaneously
por: Foltz, Steven M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fujohc009tcv7rqniv34ak192p